Yousif Capital Management LLC lessened its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 8.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 18,496 shares of the semiconductor company’s stock after selling 1,713 shares during the quarter. Yousif Capital Management LLC’s holdings in Synopsys were worth $8,977,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. State Street Corp boosted its holdings in Synopsys by 1.7% in the third quarter. State Street Corp now owns 6,948,473 shares of the semiconductor company’s stock worth $3,518,637,000 after acquiring an additional 119,057 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Synopsys by 1.9% in the 3rd quarter. Geode Capital Management LLC now owns 3,281,867 shares of the semiconductor company’s stock valued at $1,656,005,000 after purchasing an additional 61,799 shares during the last quarter. Edgewood Management LLC boosted its stake in Synopsys by 18.9% in the 3rd quarter. Edgewood Management LLC now owns 3,069,848 shares of the semiconductor company’s stock worth $1,554,540,000 after purchasing an additional 487,025 shares in the last quarter. Van ECK Associates Corp grew its position in Synopsys by 26.5% during the 3rd quarter. Van ECK Associates Corp now owns 1,605,001 shares of the semiconductor company’s stock worth $791,923,000 after purchasing an additional 335,993 shares during the last quarter. Finally, Parnassus Investments LLC acquired a new position in Synopsys during the 3rd quarter valued at approximately $633,469,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
Insider Buying and Selling at Synopsys
In other Synopsys news, CRO Richard S. Mahoney sold 20,838 shares of the firm’s stock in a transaction that occurred on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total value of $10,544,236.38. Following the sale, the executive now directly owns 1,460 shares of the company’s stock, valued at approximately $738,774.60. This trade represents a 93.45 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.66% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Report on SNPS
Synopsys Price Performance
NASDAQ:SNPS opened at $528.42 on Thursday. The company has a 50 day moving average price of $514.82 and a 200-day moving average price of $519.39. Synopsys, Inc. has a 1-year low of $457.52 and a 1-year high of $629.38. The firm has a market cap of $81.68 billion, a price-to-earnings ratio of 36.39, a price-to-earnings-growth ratio of 3.44 and a beta of 1.12.
Synopsys Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- Most active stocks: Dollar volume vs share volume
- 3 Must-Have ETFs Set to Dominate This Quarter
- The Most Important Warren Buffett Stock for Investors: His Own
- Seeking Stability? These 3 Stocks Offer Strong Potential
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.